Battle for obesity biotech Metsera heats up as Pfizer sues to block rival bid
FTC fast-tracks antitrust approval of earlier deal in sign Washington could weigh in on takeover battle with Novo Nordisk
FTC fast-tracks antitrust approval of earlier deal in sign Washington could weigh in on takeover battle with Novo Nordisk

Biotech says it opted for revised offer from US pharma company after rival Novo bid raised antitrust concerns

Danish company vies with Pfizer for control of US biotech as they seek edge in growing market for weight-loss drugs

Pfizer had struck deal in September to buy obesity-focused biotech

Deal would be the biggest by a large pharma company buying a foothold in the lucrative weight-loss drug market

Two groups fight for edge in one of the most lucrative drug classes in pharmaceutical industry history

Pharma giant had to pay a blockbuster price to buy Metsera after the biotech prospect spurred an auction with Novo Nordisk